Key result
Patients with schizophrenia exhibited pronounced ventricular repolarization abnormalities compared to healthy controls, including markedly elevated QTc dispersion.
Why the study?
Patients with schizophrenia face an increased risk of sudden cardiac death not fully explained by conventional cardiovascular risk factors or QTc prolongation alone, and novel markers of ventricular repolarization heterogeneity may better indicate arrhythmic vulnerability.
Are traditional and novel ECG markers of ventricular repolarization heterogeneity altered in adults with schizophrenia compared to healthy controls?
Meta-Analysis (n=29,284)
Are traditional and novel ECG markers of ventricular repolarization heterogeneity altered in adults with schizophrenia compared to healthy controls?
Schizophrenia is associated with pronounced ventricular repolarization heterogeneity, evident even in drug-naïve patients, suggesting increased arrhythmic vulnerability beyond conventional QTc prolongation.
Answers are grounded in this paper and cite their sources.
Warrants arrhythmia vigilance in schizophrenia; leaves open prognostic value and need for prospective outcome trials.
BACKGROUND: Patients with schizophrenia experience a markedly increased risk of sudden cardiac death that cannot be fully explained by conventional cardiovascular risk factors or QTc prolongation alone. Novel electrocardiographic markers reflecting ventricular repolarization heterogeneity may provide more sensitive indicators of arrhythmic vulnerability. METHODS: We conducted a systematic review and meta-analysis of observational studies published between 2015 and 2025 comparing traditional and novel ECG repolarization markers in adults with schizophrenia and healthy controls. PubMed, Scopus, Embase, and Web of Science were searched. Outcomes included heart rate, QT/QTc indices, frontal QRS-T angle, Tp-e interval, Tp-e/QT ratio, and dispersion measures. Pooled mean differences (MDs) with 95% confidence intervals were estimated using random-effects models, with subgroup analyses according to treatment status (drug-naïve vs medicated). RESULTS: Eleven studies comprising 5648 patients with schizophrenia and 23,636 healthy controls were included. Compared with controls, patients with schizophrenia exhibited a higher heart rate (MD = 6.24 bpm, 95% CI 2.01-10.46), increased QT dispersion (MD = 13.00 ms, 95% CI 3.58-22.42), and markedly elevated QTc dispersion (MD = 21.23 ms, 95% CI 18.23-24.23), while QTc prolongation was modest and QT interval showed no significant difference. Novel repolarization markers demonstrated pronounced abnormalities, including an increased frontal QRS-T angle (MD = 26.11°, 95% CI 19.10-33.11), prolonged Tp-e interval (MD = 3.92 ms, 95% CI 2.35-5.49), and greater Tp-e dispersion (MD = 8.21 ms, 95% CI 6.56-9.85), whereas the Tp-e/QT ratio did not differ significantly. These electrophysiological alterations were consistently observed in both drug-naïve and medicated patients. CONCLUSIONS: Schizophrenia is associated with pronounced ventricular repolarization heterogeneity that extends beyond conventional QTc prolongation and is evident even in drug-naïve patients. To our knowledge, this is the first systematic review and meta-analysis to comprehensively quantify both traditional and novel ventricular repolarization markers in schizophrenia.
No takes yet. Share an insight, caveat, or question.
Arsyi et al. (2026) conducted a meta-analysis in Schizophrenia (n=29,284). Schizophrenia vs. Healthy controls was evaluated on QTc dispersion (MD 21.23 ms, 95% CI 18.23-24.23). Patients with schizophrenia exhibited pronounced ventricular repolarization abnormalities compared to healthy controls, including markedly elevated QTc dispersion.
Synapse has enriched 10 related papers. Consider them for comparative context: